941280-51-9 Usage
Derivative of propionic acid
It is a modified version of propionic acid This means that the compound is structurally related to propionic acid, with some modifications in its chemical structure.
Class
Nonsteroidal anti-inflammatory drugs (NSAIDs) This places the compound in a category of drugs that are known for their anti-inflammatory, analgesic, and antipyretic properties.
Anti-inflammatory
May help reduce inflammation in the body This is a potential therapeutic effect of the compound, which could be useful in treating conditions with inflammation.
Analgesic
May help relieve pain This is another potential therapeutic effect, which could make the compound useful for pain management.
Antipyretic
May help reduce fever This property could be beneficial in treating conditions with elevated body temperature.
Need for further research
Therapeutic potential is not yet fully understood More studies are required to determine the compound's effectiveness and safety for medical use.
Presence of bromine and chlorine substituents
Makes the compound an interesting target for medicinal chemistry studies The presence of these substituents on the phenyl rings may contribute to the compound's potential therapeutic effects and could be a focus for researchers looking to develop new pharmaceutical agents.
Aim of studies
To develop new pharmaceutical agents with improved efficacy and reduced side effects The ultimate goal of researching this compound is to create better medications with more effective results and fewer side effects for patients.
Check Digit Verification of cas no
The CAS Registry Mumber 941280-51-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,1,2,8 and 0 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 941280-51:
(8*9)+(7*4)+(6*1)+(5*2)+(4*8)+(3*0)+(2*5)+(1*1)=159
159 % 10 = 9
So 941280-51-9 is a valid CAS Registry Number.
941280-51-9Relevant articles and documents
Catalytic, enantioselective synthesis of taranabant, a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity
Chen, G-Yi,Frey, Lisa F.,Shultz, Scott,Wallace, Debra J.,Marcantonio, Karen,Payack, Joeseph F.,Vazquez, Enrique,Springfield, Shawn A.,Zhou, George,Liu, Ping,Kieczykowski, Gerard R.,Chen, Alex M.,Phenix, Brian D.,Singh, Utpal,Strine, Jeff,Izzo, Brianne,Krska, Shane W.
, p. 616 - 623 (2007)
Chiral amide 1 (MK-0364, taranabant) is a potent, selective, and orally bioavailable cannabinoid-1 receptor (CB-1R) inverse agonist indicated for the treatment of obesity. An asymmetric synthesis featuring a dynamic kinetic resolution via hydrogenation fo
RADIOLABELED CANNABINOID-1 RECEPTOR MODULATORS
-
Page/Page column 32, (2010/02/10)
The present invention relates to particular radiolabeled Cannabinoid-1 (CB1) receptor modulators, and methods of using these modulators for labeling and diagnostic imaging of Cannabinoid-1 receptors in mammals, particularly humans. In addition, intermediates useful for the synthesis of the radiolabeled Cannabinoid-1 receptor modulators are also disclosed, as well as the processes for synthesizing the radiolabeled Cannabinoid-1 receptor modulators. Still further, formulations of the radiolabeled Cannabinoid-1 receptor compounds are described.
